Lv2
176 积分 2025-03-19 加入
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
1个月前
已完结
Consolidative thoracic radiotherapy in the immunotherapy era for extensive-stage small cell lung cancer: a systematic review and meta-analysis with emphasis on brain and liver metastases
1个月前
已完结
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
1个月前
已完结
Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study
1个月前
已完结
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing
1个月前
已完结
The role of radiotherapy in patients with resected ampullary carcinoma: findings based on SEER database
1个月前
已完结
Adjuvant therapy for ampullary carcinomas: The Mayo Clinic experience
1个月前
已完结
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial
1个月前
已完结
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial
2个月前
已完结
皖公网安备34019202002308
